Lightning Round: Jim Cramer Weighs In On GW Pharma, Snap-on, Teekay And More

On CNBC's "Mad Money Lightning Round", Jim Cramer said he can't recommend a long position in Snap-on Incorporated (NYSE: SNA) because of weak sales. read more

Continue reading at Benzinga →